John Bradley Sorenson sold $128k of BSX
EVP, Global Operations at BOSTON SCIENTIFIC CORP. 1,201 shares at an average of $106.31, traded Feb 14, 2025, filed Feb 18, 2025.
Score components
- +15RoleOfficer
- +11Trade size$128k at market
- 0Share of holdings soldSold 4.5% of holdings
- +15Cluster8 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-001878, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 14, 2025 | MOption exercise Common Stock10b5-1 | +2,115 | $0.00 | $0 | 27,609 | Feb 18, 2025 |
| Feb 14, 2025 | FTax withholding Common Stock10b5-1 | -965 | $106.11 | $102k | 26,644 | Feb 18, 2025 |
| Feb 14, 2025 | SOpen-market sale Common Stock10b5-1 | -1,201 | $106.31 | $128k | 25,443 | Feb 18, 2025 |
| Feb 16, 2025 | MOption exercise Common Stock10b5-1 | +1,273 | $0.00 | $0 | 26,716 | Feb 18, 2025 |
| Feb 16, 2025 | FTax withholding Common Stock10b5-1 | -581 | $106.11 | $62k | 26,135 | Feb 18, 2025 |
| Feb 17, 2025 | MOption exercise Common Stock10b5-1 | +1,500 | $0.00 | $0 | 27,635 | Feb 18, 2025 |
| Feb 17, 2025 | FTax withholding Common Stock10b5-1 | -684 | $106.11 | $73k | 26,951 | Feb 18, 2025 |
| Feb 13, 2025 | AGrant or award Restricted Stock Unitsderivative10b5-1 | +4,239 | $0.00 | $0 | 4,239 | Feb 18, 2025 |
| Feb 13, 2025 | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +10,909 | $0.00 | $0 | 10,909 | Feb 18, 2025 |
| Feb 14, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,115 | $0.00 | $0 | 4,230 | Feb 18, 2025 |
| Feb 16, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,273 | $0.00 | $0 | 1,273 | Feb 18, 2025 |
| Feb 17, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,500 | $0.00 | $0 | 0 | Feb 18, 2025 |
Related signals
Other insiders at BOSTON SCIENTIFIC CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.8M 56,372 shares | -24% | |
| 35Weak | BOSTON SCIENTIFIC CORP | Michael F Mahoney Chairman, President & CEO | $17M 164,443 shares | -10% | |
| 51Moderate | BOSTON SCIENTIFIC CORP | Edward J Ludwig director | $418k 4,000 shares | -15% | |
| 33Weak | BOSTON SCIENTIFIC CORP | Vance R Brown SVP, GC and Corp. Secretary | $514k 4,826 shares | -13% | |
| 18Weak | BOSTON SCIENTIFIC CORP | John Bradley Sorenson EVP, Global Operations | $478k 4,572 shares | -20% | |
| 40Moderate | BOSTON SCIENTIFIC CORP | Arthur C Butcher EVP& Grp Pres, MedSurg & APAC | $1.8M 17,314 shares | -44% | |
| 30Weak | BOSTON SCIENTIFIC CORP | Michael F Mahoney Chairman, President & CEO | $17M 164,443 shares | -10% | |
| 32Weak | BOSTON SCIENTIFIC CORP | Vance R Brown SVP, GC and Corp. Secretary | $459k 4,826 shares | -12% | |
| 23Weak | BOSTON SCIENTIFIC CORP | Michael F Mahoney Chairman, President & CEO | $16M 164,442 shares | -9% | |
| 26Weak | BOSTON SCIENTIFIC CORP | Vance R Brown SVP, GC and Corp. Secretary | $487k 4,826 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.